Pain Reprocessing Therapy for persistent knee pain after knee replacement
Official title: Efficacy and Mechanisms of Pain Reprocessing Therapy in Chronic Post-Operative Knee Pain
Run by Weill Medical College of Cornell University · NCT06800209 · Data updated 2026-11-12
This trial will test whether Pain Reprocessing Therapy (PRT) delivered by video can reduce persistent knee pain in adults who still have meaningful pain three months after knee replacement.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 2 sites (Aurora, Colorado and 1 other locations) |
| Status | Recruiting |
| Started | August 13, 2025 |
| Main results expected | September 30, 2027 |
| Study ends | September 29, 2028 |
| Registry record updated | August 5, 2026 |
| Trial ID | NCT06800209 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults who had a primary knee replacement, reported chronic knee pain before surgery, and continue to have moderate pain (average ≥4/20 and specific WOMAC criteria) at three months post-op.
✕Probably not a fit
Patients without ongoing pain at three months, those who had a revision rather than a primary knee replacement, those unwilling to use telehealth, or those with exclusionary psychiatric or medical conditions are unlikely to benefit from enrolling.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with chronic pre-operative knee pain who continue to have pain three months after a primary knee replacement are randomized to eight weekly telehealth PRT sessions or to usual post-operative care. Participants complete questionnaires on pain intensity, function, anxiety, depression, and sleep, and a subset may undergo optional EEG to measure brain activity related to pain. The PRT intervention uses cognitive, exposure-based, and somatic techniques to help patients reconceptualize pain as reversible brain-driven activity rather than ongoing tissue damage. Outcomes and mediation analyses will measure clinical effects at post-treatment and over longitudinal follow-up and test psychological and neurobiological mechanisms.
Why it matters
Potential benefit: If successful, PRT could provide a scalable, non-drug therapy that reduces or even eliminates chronic post-operative knee pain and improves mood and sleep.
How similar studies have gone: A prior randomized trial of PRT for chronic back pain (N=151) showed large benefits (about 66% pain-free or nearly pain-free post-treatment versus <20% for controls), but PRT has not yet been tested for chronic post-operative knee pain or widely by telehealth.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients are deemed eligible at 3 months post-operatively if: The patient completed a primary knee replacement \[surgery completed without complication and patient exhibits full mechanical joint function, as determined by the treating physician (good range of motion, stability, and wound healing; absence of swelling)\] and patient reports last week average knee pain ≥ 4 of 20 and at least two questions rated 'moderate' on A 12-item shortened version (ShortMAC) of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). * Reported pre-operative chronic knee pain of at least 6 months duration prior to surgery * The procedure was a primary (not a revision) knee replacement * Proficient in English Exclusion Criteria: * Patients who are not willing to participate in a telehealth visit. * Patients with pre-op chronic pain but who do not have post-operative pain after the three month time period. * Active suicidal ideation with intent, recent history of suicide attempt, or self-harm behaviors within the past 5 years (including non-suicidal self-harm). * Recent history of inpatient psychiatric hospitalization within the past 5 years. * Active, current psychosis or mania. * Active, current substance abuse, or problems with substance abuse within the past 2 years. * Instability in living conditions or major interfering life events: * Major surgery or other major medical event planned in coming 6 months. * Uncertain whether they will have suitable conditions for telehealth appointments over the next 2 months, including access to a computer or tablet, reliable high-speed internet, and a quiet, comfortable room that is consistently available. * Major, interfering changes in employment or housing anticipated over the next 6 months. * Neurological conditions (e.g., Alzheimer's, dementia, mild cognitive impairment, Huntington's disease, multiple sclerosis, cerebral palsy). This will be case-by-case decision made by PI to determine if the condition may interfere with treatment and warrant exclusion. * Self-reported diagnosis of an autoimmune disease (e.g., rheumatoid arthritis, polymyalgia rheumatica, scleroderma, lupus, polymyositis, or another autoimmune disorder). * Currently or plan to be involved in lawsuits related to pain in next 6 months, currently or plan to apply for any disability payments related to the pain in next 6 months, or received legal settlement or other disability payments related to the pain over past 2 years. EEG Exclusion Criteria (patients can still be enrolled as long as they meet all other eligibility criteria; however, they will not undergo EEG testing): * Are unable or uncomfortable with completing a dry cap EEG. * Has had a history of abnormal EEGs. * Had bilateral TKA
Where it's running
-
Hospital for Special Surgery
New York, New York, United States Recruiting -
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States Active not recruiting
Study contacts
- Principal investigator: Cary Reid, MD, PhD — Weill Medical College of Cornell University
- Study coordinator: Allina Nocon, PhD
- Email: Complexjoint@hss.edu
- Phone: 212-774-2572
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain scans to find links between brain activity and knee replacement outcomes
This study uses brain MRI before and after knee replacement to see if patterns of brain activity can predict which patients will be satisfied with their surgery.
-
Therapeutic yoga and interoceptive awareness in adolescents with chronic pain
This will test whether an occupational therapy plan that includes therapeutic yoga helps adolescents (ages 11–21) with chronic pain improve body awareness and day-to-day function.
-
Butyrate and Taurine for Chronic Postoperative Pain in Adults after Cardiac Surgery
This study tests whether taking taurine and butyrate daily can reduce long-lasting pain after cardiac surgery in adults.
-
VMD-3866 topical gel for chemotherapy-induced nerve pain
This trial will test whether a non-opioid topical gel called VMD-3866 can reduce pain in adults with chemotherapy-induced peripheral neuropathy.
-
810 nm light therapy for chronic knee pain and synovitis
This trial will test whether 810 nm light therapy can reduce pain and knee inflammation in adults aged 40–80 with chronic knee pain and ultrasound-confirmed synovitis.
-
BioPoly implant for knee cartilage defects
This study is testing a new knee implant to see if it can help adults with cartilage damage feel better and avoid more surgery compared to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.